Zobrazeno 1 - 10
of 497
pro vyhledávání: '"Per, Winkel"'
Autor:
Zamba, Gideon (K.D.)
Publikováno v:
The American Statistician, 2008 Nov 01. 62(4), 359-360.
Externí odkaz:
https://www.jstor.org/stable/27644070
Autor:
Hand, David J.
Publikováno v:
International Statistical Review / Revue Internationale de Statistique, 2007 Dec 01. 75(3), 417-417.
Externí odkaz:
https://www.jstor.org/stable/41509888
Autor:
Hyltoft Petersen, P.
Publikováno v:
Hyltoft Petersen, P 2002, ' Boganmeldelse af Per Winkel: Statistisk kvalitetsudvikling i klinik og laboratorium ', Klinisk Kemi i Norden, bind 14, s. 15 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::e92bf6e074bdb33829533724ea3bd50c
https://portal.findresearcher.sdu.dk/da/publications/7b222250-a8af-11dc-9626-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/7b222250-a8af-11dc-9626-000ea68e967b
Autor:
David J. Hand
Publikováno v:
International Statistical Review. 75:417-417
Autor:
Per Winkel, Jørgen Hilden, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud, Kasper Karmark Iversen, Gorm Boje Jensen, Mette Bjerre
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Objective To assess if 12 novel circulating biomarkers, when added to ‘standard predictors’ available in general practice, could improve the 10-year prediction of cardiovascular events and mortality in patients with stable coronary heart disease.
Externí odkaz:
https://doaj.org/article/6b24de0522e94d5a897eb0bdd7ac0592
Autor:
Jakob Schroder, Janus Christian Jakobsen, Per Winkel, Jørgen Hilden, Gorm Boje Jensen, Ahmad Sajadieh, Anders Larsson, Johan Ärnlöv, Marina Harutyunyan, Julia S. Johansen, Erik Kjøller, Christian Gluud, Jens Kastrup
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 5 (2020)
Background The inflammatory biomarker YKL‐40 has previously been studied as a potential risk marker in cardiovascular disease. We aimed to assess the prognostic reclassification potential of serum YKL‐40 in patients with stable coronary artery di
Externí odkaz:
https://doaj.org/article/9f843d85bdcb456caaf6e47317d0da18
Autor:
Ida Elisabeth Højskov, Philips Moons, Ingrid Egerod, Peter Skov Olsen, Lau Caspar Thygesen, Niels Viggo Hansen, Søren La Cour, Krisitna Hindhede Bech, Britt Borregaard, Christian Gluud, Per Winkel, Jane Lindschou, Selina Kikkenborg Berg
Publikováno v:
Journal of Rehabilitation Medicine, Vol 51, Iss 2, Pp 136-143 (2018)
Objectives: Rehabilitation of patients following coronary artery bypass grafting (CABG) has been widely studied; however, research into early rehabilitation after CABG is sparse. The aim of this trial was to assess the impact of early rehabilitation,
Externí odkaz:
https://doaj.org/article/69319e65be6d4deb81424159ea8b8992
Autor:
Maja H Fisker, Niels Erik Ebbehøj, Søren Grove Vejlstrup, Jane Lindschou, Christian Gluud, Per Winkel, Jens Peter Bonde, Tove Agner
Publikováno v:
Scandinavian Journal of Work, Environment & Health, Vol 44, Iss 2, Pp 212-218 (2018)
OBJECTIVE: Occupational hand eczema has adverse health and socioeconomic impacts for the afflicted individuals and society. Prevention and treatment strategies are needed. This study aimed to assess the effectiveness of an educational intervention on
Externí odkaz:
https://doaj.org/article/f6c9ef33a7e44d1fb61edc4f4436e478
Publikováno v:
BMC Medical Research Methodology, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background Missing data may seriously compromise inferences from randomised clinical trials, especially if missing data are not handled appropriately. The potential bias due to missing data depends on the mechanism causing the data to be mis
Externí odkaz:
https://doaj.org/article/1da0c2ef4e514b7fb7818310bd7e5a4e
Autor:
Per Winkel, Philip M. Bath, Christian Gluud, Jane Lindschou, H. Bart van der Worp, Malcolm R. Macleod, Istvan Szabo, Isabelle Durand-Zaleski, Stefan Schwab, for the EuroHYP-1 trial investigators
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-12 (2017)
Abstract Background Cooling may reduce infarct size and improve neurological outcomes in patients with ischaemic stroke. In phase II trials, cooling awake patients with ischaemic stroke has been shown to be feasible and safe, but the effects in funct
Externí odkaz:
https://doaj.org/article/4d680664b0324af890bba8f22c893b73